Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus

Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2029-2032. doi: 10.1007/s10096-021-04219-0. Epub 2021 Mar 8.

Abstract

We report a case of osteomyelitis due to methicillin-resistant Staphylococcus aureus (MRSA) that is also non-susceptible to vancomycin, dalbavancin, ceftaroline, and ceftobiprole, in the absence of exposure to the latter three antibiotics. It was isolated from a patient with a 26-year history of cranial surgeries and episodes of osteomyelitis. Whole-genome sequencing was performed. It was found to belong to ST247 and the mecA gene was detected within the SSCmec type I (1B) gene cassette that lacked the E447K mutation known to produce resistance to ceftobiprole and ceftaroline. However, mutations in other genes related to resistance to these antibiotics were found.

Keywords: Ceftaroline; Ceftobiprole; Dalbavancin; MRSA; Osteomyelitis; Staphylococcus aureus.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Ceftaroline
  • Cephalosporins / pharmacology*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification
  • Microbial Sensitivity Tests
  • Osteomyelitis / diagnosis*
  • Osteomyelitis / microbiology
  • Teicoplanin / analogs & derivatives*
  • Teicoplanin / pharmacology
  • Vancomycin / pharmacology*
  • Whole Genome Sequencing

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Teicoplanin
  • Vancomycin
  • dalbavancin